SG11202111149VA - Plasmid system - Google Patents

Plasmid system

Info

Publication number
SG11202111149VA
SG11202111149VA SG11202111149VA SG11202111149VA SG11202111149VA SG 11202111149V A SG11202111149V A SG 11202111149VA SG 11202111149V A SG11202111149V A SG 11202111149VA SG 11202111149V A SG11202111149V A SG 11202111149VA SG 11202111149V A SG11202111149V A SG 11202111149VA
Authority
SG
Singapore
Prior art keywords
plasmid system
plasmid
Prior art date
Application number
SG11202111149VA
Inventor
Markus Hörer
Florian Sonntag
Renée Kober
Original Assignee
Freeline Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1905263.8A external-priority patent/GB201905263D0/en
Priority claimed from EP19169121.1A external-priority patent/EP3722434B1/en
Application filed by Freeline Therapeutics Ltd filed Critical Freeline Therapeutics Ltd
Publication of SG11202111149VA publication Critical patent/SG11202111149VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
SG11202111149VA 2019-04-12 2020-04-14 Plasmid system SG11202111149VA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1905263.8A GB201905263D0 (en) 2019-04-12 2019-04-12 Plasmid system
EP19169121.1A EP3722434B1 (en) 2019-04-12 2019-04-12 Plasmid system
PCT/GB2020/050947 WO2020208379A1 (en) 2019-04-12 2020-04-14 Plasmid system

Publications (1)

Publication Number Publication Date
SG11202111149VA true SG11202111149VA (en) 2021-11-29

Family

ID=70295566

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202111149VA SG11202111149VA (en) 2019-04-12 2020-04-14 Plasmid system

Country Status (11)

Country Link
US (1) US20220162642A1 (en)
EP (1) EP3953482A1 (en)
JP (1) JP7562558B2 (en)
KR (1) KR20220019669A (en)
CN (1) CN113891942A (en)
AU (1) AU2020272557A1 (en)
BR (1) BR112021020401A2 (en)
CA (1) CA3136545A1 (en)
IL (2) IL296544A (en)
SG (1) SG11202111149VA (en)
WO (1) WO2020208379A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3722434T (en) 2019-04-12 2022-10-18 Freeline Therapeutics Ltd Plasmid system
CA3158995A1 (en) 2019-11-01 2021-05-06 Freeline Therapeutics Limited Transcription regulatory elements
BR112023016997A2 (en) 2021-02-26 2023-11-07 Logicbio Therapeutics Inc MANUFACTURING AND USE OF RECOMBINANT AAV VECTORS
EP4410971A1 (en) 2021-09-30 2024-08-07 FUJIFILM Corporation Method for producing adeno-associated virus, cells and expression vector
GB202214328D0 (en) 2022-09-29 2022-11-16 Freeline Therapeutics Ltd Method
WO2024160232A1 (en) * 2023-02-01 2024-08-08 纽福斯(苏州)生物科技有限公司 Plasmid packaging system and use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10066104A1 (en) 2000-09-08 2003-01-09 Medigene Ag Host cells for packaging recombinant adeno-associated virus (rAAV), process for their preparation and their use
CA2453405A1 (en) 2001-07-13 2003-01-23 University Of Iowa Research Foundation Pseudotyped adeno-associated viruses and uses thereof
US20050080027A1 (en) 2001-11-30 2005-04-14 Markus Horer Optimized production of viral vectors derived from paroviruses in packaging and production cells by hsv infection or treatment with dna methylation inhibitors
ES2330826B1 (en) * 2008-06-04 2010-07-26 Proyecto De Biomedicina Cima, S.L. HIGH CAPACITY ADENOVIRUS PACKING SYSTEM.
CN102341406B (en) * 2009-03-04 2016-06-08 德国癌症研究中心 Assemble-activated protein (AAP) and its use for preparing parvoviral particles consisting essentially of VP3
WO2013029030A1 (en) 2011-08-24 2013-02-28 The Board Of Trustees Of The Leland Stanford Junior University New aav capsid proteins for nucleic acid transfer
JP6348064B2 (en) 2011-11-22 2018-06-27 ザ チルドレンズ ホスピタル オブ フィラデルフィア Viral vectors for efficient transgene delivery
GB201420139D0 (en) 2014-11-12 2014-12-24 Ucl Business Plc Factor IX gene therapy
GB201508026D0 (en) 2015-05-11 2015-06-24 Ucl Business Plc Capsid
WO2017096164A1 (en) 2015-12-02 2017-06-08 The Board Of Trustees Of The Leland Stanford Junior University Novel recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
CN108048483B (en) * 2018-01-30 2021-02-02 中国疾病预防控制中心病毒病预防控制所 Replication type recombinant adenovirus HAdV-5 vector system and application thereof

Also Published As

Publication number Publication date
US20220162642A1 (en) 2022-05-26
IL287100A (en) 2021-12-01
JP2022530192A (en) 2022-06-28
CA3136545A1 (en) 2020-10-15
CN113891942A (en) 2022-01-04
KR20220019669A (en) 2022-02-17
BR112021020401A2 (en) 2021-12-07
AU2020272557A1 (en) 2021-12-09
WO2020208379A1 (en) 2020-10-15
JP7562558B2 (en) 2024-10-07
IL296544A (en) 2022-11-01
EP3953482A1 (en) 2022-02-16

Similar Documents

Publication Publication Date Title
GB2597191B (en) Product-display system
IL286570A (en) System
IL287100A (en) Plasmid system
PL3722434T3 (en) Plasmid system
IL287309A (en) Electrosurgical system
PL3693325T3 (en) Delivery system
GB2594877B (en) Feeding system
SG11202107323SA (en) Electrode system
SG11202112164VA (en) Novel lower-trolley system
GB201907302D0 (en) Delivery system
IL287160A (en) Electrosurgical system
GB2616987B (en) Connection system
EP3924957C0 (en) Cloth-tensioning system
SG11202111516UA (en) Event system
GB201900281D0 (en) Securing system
GB2590093B (en) Connection system
GB202016254D0 (en) Plasmid system
EP4069093A4 (en) Bioprinting system
EP3979930C0 (en) Microintroducer system
PL3763905T3 (en) Fitting system
EP3962392C0 (en) Electrosurgical system
SI3543421T1 (en) Adjusting system
GB201905263D0 (en) Plasmid system
SG11202011630VA (en) Shoulder-massaging system
GB201917537D0 (en) E-marking system